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Excessive excitation or loss of inhibitory neurotransmission has been closely related to epileptic activity. Somatostatin (SST) and 
Neuropeptide Y (NPY) are members of endogenous neuropeptides which are recognized as important modulator of classical 
neurotransmitter, distributed abundantly in mammalian central nervous system. Abnormal expression of these two neuropeptides 
evidenced in some epileptic models highlights the relevance of SST or NPY in the pathogenesis of epilepsy. The tremor rat (TRM) 
is a genetic epileptic animal model which can manifest tonic convulsions without any external stimuli. The present study aimed to 
investigate the distribution and expression of SST and NPY in TRM brains, including hippocampus, temporal lobe cortex and cerebellum. 
Our RT‑PCR data showed that up‑regulated mRNA expression of SST and NPY was discovered in TRM hippocampus and temporal lobe 
cortex compared with control (Wistar) rats. The peptide levels of these neuropeptides in brain areas mentioned above were both 
apparently higher than that in normal Wistar rats as well. However, in cerebellums, neither SST nor NPY was significantly changed 
compared with control group. The immunohistochemical data showed that SST and NPY were widely present throughout CA1, CA3 
and the hilus of hippocampus, the entorhinal cortex of temporal lobe cortex, as well as cerebellar Purkinje layer. In conclusion, our 
results discovered the aberrant changes of SST and NPY in several TRM brain regions, suggesting that the peptidergic system might be 
involved in TRM epileptiform activity. 
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INTRODUCTION
Epilepsy is one of the most common chronic 
neurological disorders which is characterized by 
recurrent and unprovoked seizures, affecting over 
70 million people worldwide (Weaver and Pohlmann-
-Eden 2013, Erfanparast and Tamaddonfard 2015). 
Although specific drugs have been developed, the side 
effects of classic antiepileptic drugs caused by their 
action mechanism could not be totally avoided (Kovac 
and Walker 2013). The disruption of the delicate balance 
between excitatory and inhibitory neurotransmission 
contributing to the overexcited neuronal activity in 
mammalian brain has been proposed to be a possible 
candidate for epileptogenesis (Madsen et al. 2009). Thus, 
as the modulators of classical neurotransmitters, such 
as γ-aminobutyric acid (GABA) and glutamate (GLU), 
neuropeptides are closely linked to epileptic diseases, 
including pathogenesis and treatment. 
Somatostatin (SST) and neuropeptide Y (NPY) are 
both belonged to endogenous neuropeptides family, 
abundantly express in neurons of brain areas and are 
likely to be preferentially released by neurons subjected 
to high-frequency stimulation. The role of SST in seizure 
is first confirmed by temporal lobe epileptic rats in which 
SST-containing neurons in the hilus of dentate gyrus are 
selectively lost (Sloviter 1987). The expression of SST could 
be markedly affected in response to seizure occurrence. For 
instance, in convulsive rats induced by repeated amygdaloid 
kindling, remarkably elevated expression of SST could 
be observed in epileptic models evoked by lidocaine and 
electroconvulsive stimulation (Nagaki et al. 2000, Mikkelsen 
and Woldbye 2006). Moreover, adeno-associated viral 
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have been both verified to be effective in suppressing or 
attenuating status epilepticus (Zafar et al. 2012, Kozhemyakin 
et al. 2013), which further illustrates that SST may serve as 
a significant anti-epileptic neuromodulator.
NPY is a highly conserved 36-amino acid neuropeptide 
produced by the neurons throughout hippocampus and 
neocortex (Husum et al. 2004). It could prevent the damages 
from excessive hyper-excitability in neurons when suffering 
harmful stimulus. During kindling epileptogenesis, NPY is 
emerging as a central modulator of seizure activity which 
undergo plastic changes (Calik et al. 2015). Acting as one of the 
inhibitors of synaptic excitability, the abnormal expression 
of NPY has been associated with its function of dampening 
seizures as well. Electroshock or kainic acid (KA) could result 
in brief experimental epileptiform symptoms, accompanied 
by increased NPY positive neurons in rat brain (Cardoso et al. 
2010, Drexel et al. 2012). In temporal lobe epilepsy induced 
by trimethyltin (TMT), intracerebroventricular injection of 
exogenous NPY may exert powerful neuroprotection and 
reduce hippocampal damage (Corvino et al. 2012).
Unlike epileptic models obtained by chemical or physical 
methods, the tremor rat (TRM, RGD ID: 1302702) (tm/tm) is a 
genetic mutant model discovered by Kyoto University. TRMs 
have seizure-like features of showing tonic convulsions 
and appearing 5–7 Hz spike-wave complexes in cortical 
and hippocampal electroencephalograms (EEGs) records 
without any external stimuli (Serikawa et al. 1987, Kondo et 
al. 1991). As a crucial animal model of hereditary epilepsy, 
TRMs have been applied in researches of GABA transporters, 
cognitive deficits and voltage-gated sodium channels 
in epileptic activity (Mao et al. 2011a, Xu et al. 2013). It is 
illustrated that homozygous TRMs showed lower levels of 
NPY than heterozygous ones in hippocampus and neocortex 
by the method of radioimmunoassay (Sadamatsu et al. 1995). 
Our group demonstrated the ectopic expression of NPY and 
its receptor subtypes in TRM brains in a previous study as 
well (Xu et al. 2014). However, the detailed alteration of 
NPY or another neuropeptide-SST compared with Wistar 
remains to be documented. Moreover, the reduction of 
cerebellar activity in experimental epilepsy is reported by 
recent research, indicating the possible role of cerebellum 
in seizures (Rijkers et al. 2015). Therefore, in the present 
study, we chiefly focused on the expression and distribution 
of SST and NPY in TRM brain areas, including hippocampus, 
temporal lobe cortex and cerebellum in order to explore the 
potential role of neuropeptides in TRM epileptogenesis.
MATERIALS AND METHODS
Experimental animals
TRMs were gifted by Kyoto University. Normal Wistar 
rats as control were from the Center for Experimental 
Animals of China Medical Univeristy. All the animals 
were maintained in individual cages under controlled 
environment (12:12 h light/dark cycle, 50–70% humidity, 
24°C). Food and water were available ad libitum. TRM (n=21) 
and Wistar rats (n=21) of both sexes at the age of 9–12 
weeks were selected as experimental animals. Three males 
and four females of TRMs or control rats were applied 
in each group. Experimental treatments were followed 
the guidelines from NIH. Meanwhile, all the handling 
procedures were approved by the Committee of Animal 
Experimentation of China Medical University. 
RT-PCR
After the rats were anaesthetized by diethyl ether and 
decapitated, the brains were quickly removed and dissected 
into hippocampus, temporal lobe cortex and cerebellum on 
ice according to the method in previous report with some 
modifications (Xu et al. 2014). Total RNA was then isolated 
from these brain regions of TRMs (n=7) and control rats 
(n=7) separately using Trizol reagent (Invitrogen, USA) 
following manufacturer’s instructions. The concentration 
of RNA was measured by spectrophotometer to make sure 
a A260/A280 ratio close to 1.8–2.0. Equal amount of RNA 
(500 ng) from each sample was used for cDNA synthesis 
in a volume of 10 µl according to the guideline in Takara 
RT reagent kit (Takara code: DRR037S). The resulting RT 
reactions as template were directly added in amplified 
mixture and incubated in PCR thermocycler for 30 cycles. 
Each PCR reaction consisted of the following: 3 µl of the 
cDNA product, 2 µl of dNTP, 1µl of each primer, 2.5 µl of 
PCR Buffer, 0.3 µl of Takara Ex Taq Enzyme and sterilized 
distilled water to a final volume of 25 µl. Each thermal 
cycle consisted of the processes as below: denaturation at 
95°C for 45 s, annealling at 60°C for 50 s, and an extension 
at 72°C for 90 s. The amplification of each template had 
been replicated for three times. GAPDH was served as an 
endogenous internal standard control. For the purpose 
of avoiding genomic DNA and external contaminations, 
RT-PCR mixture with no reverse transcriptase and PCR 
mixture lacked of cDNA template were performed as 
control. PCR products were electrophoresed on 2% agarose 
gel containing ethidium bromide and the anticipated 
targeted bands were visualized under ultraviolet light. 
The intensities of products were quantified via Quantity 
one software. Then the ratio of SST to GAPDH and NPY 
to GAPDH were calculated respectively to normalize the 
expressions of these gene on mRNA level.
Primer sequences for SST, NPY and GAPDH were as 
follows: SST, forward: 5’-ATCGTCCTGGCTTTGGGC-3’ 
reverse: 5’-GCCTCATCTCGTCCTGCTCA-3’; NPY, 
forward: 5’-TAGGTAACAAACGAATGGGG-3’ reverse: 
5’-AGGATGAGATGAGATGTGGG-3’; GAPDH, forward: 
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5’-GGCACAGTCAAGGCTGAGAATG-3’’; reverse: 
5’-ATGGTGGTGAAGACGCCAGTA-3’’, which generated 
a 207 bp, 350 bp and 143 bp fragments, respectively.
ELISA
Tissue samples from hippocampus, temporal lobe 
cortex and cerebellum of experimental animals of both 
sexes (TRMs n=7 and control rats n=7) were separated as 
aforementioned description on ice, then homogenized 
in PBS and centrifuged at 13500 rpm for 20 min at 4oC. 
The concentrations of SST and NPY were determined 
by enzyme-linked immunosorbent assay (ELISA) kits, 
following the instructions of manufacturer (USCN, SST 
code: CEA592Ra; NPY code: CEA879Ra, China). In brief, the 
diluted samples and standards were added into the wells 
of microplates pre-coated by antibodies of SST or NPY. 
Then added prepared detection reagent A immediately 
and incubated 1 h at 37oC. After rinsing, prepared Detection 
Reagent B was added and incubated 30 min at 37oC. 
Substrate solution and stop solution were respectively 
added after washing three times and the data could be read 
at 450 nm immediately by microplate reader. Each samples 
had been replicated for three times and the calculated 
concentrations would be averaged.
Immunohistochemistry
The brains from TRMs (n=7) and control rats (n=7) of 
either sex were embedded in paraffin after fixing in 4% 
paraformaldehyde. For each animal, 100 and 50 serial 
coronal sections of 4 μm thick from hippocampus and 
cerebellum were cut respectively. For each targeted 
protein, six sections selected from the rostral, middle 
and caudal part of the serial sections were treated with 
immunohistochemical process (2 sections for each part, 
and in total, 6 sections of hippocampus and 6 sections 
of cerebellum from one rat). In brief, sections were 
deparaffinized and dehydrated in graded alcohol, then 
treated with 3% H2O2 for 15 min for inhibiting endogenous 
peroxidases. After rinsing, the slices were blocked in 10% 
normal goat serum for 20 min, followed by an incubation 
with rabbit anti-SST diluted by 1% normal goat serum 
at 1:50 (ab103790, Abcam) or rabbit anti-NPY diluted by 
1% normal goat serum at 1:20 (12833-1-AP, Proteintech, 
China) overnight at 4°C. Sections were then stained with 
secondary antibodies biotinylated anti-rabbit IgG diluted 
by PBS at 1:100. After incubation with DAB kit for 10 min, 
the slides were counterstained by hematoxylin. Negative 
control sections were incubated with 10% normal goat 
serum without primary antibodies. The cellular localization 
and distribution of targeted proteins were observed 
under light microscope and the estimation of density of 
immuno-positive cells in subregions of brains followed the 
process in previous researches (Guo et al. 2013), including 
hippocampal CA1, CA3 and hilus, the entorhinal cortex 
of temporal lobe cortex and cerebellum. The fields to be 
counted were located by the characteristic landmarks in 
the histological map, such as the folding of the pyramidal 
cell layer in areas of CA1 and CA3. The immuno-positive 
cells within 100 cells of every location were counted in 
blinded fashion. Three counters who did not know the 
sections from which group were asked to count the same 
field and their results were averaged. Estimating density of 
positive cells and capturing images were carried out under 
a microscopic enlargement of ×200 and ×400, respectively. 
Statistical analysis
All data were presented as mean ±SD. Student’s t-test 
was performed to evaluate the individual comparisons 
between different groups, and statistical significance level 
was set for p values <0.05. All statistical analyses were 
conducted using SPSS for Windows version 16.0.
RESULTS
The expressions of SST and NPY in TRM brains on 
mRNA level
RT-PCR was first carried out in order to measure 
the expression of SST and NPY on mRNA level in the 
subregions of TRM and control rat brains. As indicated in 
Fig. 1, the mRNA expression of SST and NPY were both 
elevated in hippocampus and temporal lobe cortex of TRM 
compared with the control rats (SST: HIP, 0.84±0.07 in TRMs 
vs. 0.45±0.04 in control rats, p<0.01; TLC, 0.77±0.05 in TRMs 
vs. 0.43±0.02 in control rats, p<0.01; NPY: HIP, 0.66±0.02 in 
TRMs vs. 0.39±0.04 in control rats, p<0.01; TLC, 0.75±0.06 
in TRMs vs. 0.60±0.02 in control rats, p<0.01). However, in 
TRM cerebellum, we did not detect abnormal expressions 
of these two neuropeptides. (SST, 0.28±0.03 in TRMs vs. 
0.30±0.06 in control rats, p>0.05; NPY, 0.26±0.04 in TRMs vs. 
0.24±0.05 in control rats, p>0.05).
The concentrations of SST and NPY in TRM brain 
tissues
In order to further quantify the concentrations 
of SST and NPY, homogenized tissue samples from 
hippocampus, temporal lobe cortex and cerebellum in 
TRMs and control rats were subjected to ELISA analysis. 
According to Fig. 2, in TRM hippocampus and temporal 
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lobe cortex, SST and NPY concentrations were both much 
higher than normal rats, whereas in TRM cerebellum, 
neither of them was changed in comparison to the 
control group. These results were similar with what we 
discovered via RT-PCR.
The distributions of SST and NPY in TRM brains
Immunohistochemical analysis was then performed 
to detect the distributions of SST and NPY. Figs 3A, 4A, 
5A and 6A indicated the two kinds of neuropeptide were 
localized abundantly in brains of TRMs and control rats, 
especially in neurons of hippocampal CA1, CA3 and hilus. 
Additionally, immunoreactivity of SST or NPY was also 
discovered on the neurons located in the entorhinal 
cortex. The positive reactions mainly appeared on cell 
bodies, partly on nerve fibers. In cerebellum, most of the 
stained cells were Purkinje cells, which were pear-like 
shapes with clear and unstained nucleus. There was 
relatively weaker signal in fibers from granular cell 
layer, while almost no obvious immuno-signal could be 
captured in molecular layer.
As shown in Figs 3B, 4B, 5B and 6B, the number of 
SST positive cells in TRMs was more than that of control 
ones, including hippocampal CA3, the hilus and temporal 
lobe cortex. However, there was no significant change in 
TRM hippocampal CA1 and cerebellum. Meanwhile, it was 
noteworthy that the NPY positive cells were extremely 
increased in all the observed brain regions of TRMs except 
cerebellum where the quantity did not show clear variation 
compared with Wistar rats. On the whole, the findings of 
immunohistochemistry were in accordance with our data 
by RT-PCR and ELISA. 
DISCUSSION
In this study, we mainly focused on the expressions 
and distributions of SST and NPY in TRM rat different 
brain areas, including hippocampus, temporal lobe cortex 
and cerebellum. The mRNA of both SST and NPY were 
up-regulated in TRM hippocampus and temporal lobe 
cortex compared with Wistar rats, accompanied with the 
dramatic elevated expressions on peptide level. However, 
in TRM cerebellum, neither of them was discovered 
abnormal expression. Our immunohistochemical results 
proved that SST and NPY were widely expressed in TRM 
hippocampal CA1, CA3 and the region of hilus, so did 
in both entorhinal cortex of temporal lobe cortex and 
cerebellar Purkinje layer. 
Fig. 1. The mRNA expression of SST and NPY in the brains of TRM and 
control rats by RT‑PCR (mean ±S.D., n=7). (A) The representative bands of 
SST and NPY mRNA expression. (B) The data analysis of relative expression 
of SST and NPY. All data represented a relative quantification to internal 
control GAPDH. The ratio of grey values for SST and NPY were both much 
higher than control rats, whereas in TRM cerebellum, neither of them had 
significant change. *p<0.05 vs. control group; **p<0.01 vs. control group. 
Con=control, HIP=hippocampus, TLC=temporal lobe cortex, CE=cerebellum.
Fig. 2. The concentrations of SST and NPY in the brain of TRM and control 
rats by ELISA (mean ±S.D., n=7). (A) The concentrations of SST and NPY 
in TRM and control brains. (B) The column charts of ELISA data. SST and 
NPY were both elevated in hippocampus and temporal lobe cortex of TRM 
compared with the control rats, but with no change in TRM cerebellum. 
**p<0.01 vs. control group.
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SST is primarily synthesized by GABAergic interneurons 
and the coexistence with a number of inhibitory 
neurotransmitters hints on its ability of attenuating neuronal 
hyperexcitability. Via contacting with particular receptors, 
SST could inhibit presynaptically release of glutamate, the 
voltage-gated calcium currents or potassium leak current, 
together with modulating postsynaptically α-amino- 
-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) 
currents in the hypothalamus (Baraban and Tallent 2004, 
Peineau et al. 2003). Intracerebroventricular administration 
of SST or its analogs could reduce the likelihood of 
epileptiform events in several epileptic models (Vezzani and 
Hoyer 1999). On the contrary, SST gene knock-out mice are 
more susceptible to stimulus from kainic acid, heightening 
seizure severity (Buckmaster et al. 2002). The reduced number 
of SST-containing neurons are reported in pilocarpine-
-induced seizures and kainate-treated rats (Buckmaster and 
Dudek 1997, Dinocourt et al. 2003). However, more evidences 
Fig. 3. The representative images of TRM and control hippocampus showing DAB‑stained SST. (A) The distribution of SST is observed in hippocampal CA1, 
CA3 and the hilus. Two each of the representative neurons which have positive or negative immuno‑signals was pointed out by arrow and arrowheads 
respectively. (B) The analysis of SST positive cells. In TRM CA3, the number of SST positive cells are more than control rats. Scale bars: 20 μm. *p<0.05 vs. 
control group; **p<0.01 vs. control group. Con=control, SR=stratum radiatum, SP=pyramidal layer, SO=stratum oriens, OB=outer blade of the dentate 
gyrus, GCL=granular cell layer, IB=inner blade of the dentate gyrus, H=hilus.
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also elucidate the expression as well as the release of this 
neuropeptide could be markedly augmented following the 
emergence of epilepsy. In the convulsive rats evoked by 
ultra-red light or kindling, the increased expression of SST 
has been discovered in both hippocampus and neocortex 
(Nagaki et al. 1996, Csaba et al. 2004). The elevated mRNA 
and peptide levels are also reported in kainic-acid epileptic 
models (Hashimoto and Obata 1991), which is consistent 
with what we found in the current research. In this regard, 
we speculate that the raise of SST in TRM hippocampus 
and temporal lobe cortex might be adaptive reactions to 
epileptogenesis for the sake of preventing neurons from 
seizure damage. There is a prototypical cAMP regulatory 
element site in SST gene, which could be activated during 
higher neuronal activity (Clynen et al. 2014). Hence, the 
altered TRM brain tissue excitability might partly contribute 
to the unusual change of SST. Additionally, SST-containing 
dense-core vesicles secretion from axon terminals is calcium-
-dependent and often occurs after high stimulation (Vezzani 
and Hoyer 1999). And according to our previous study, the 
concentration of Ca2+ in TRM hippocampal neurons were 
significantly increased (Lv et al. 2015), suggesting another 
potential reason for SST variation. 
NPY is widely expressed in GABAergic interneurons 
and may coexist with SST in mammalian central nervous 
system, such as hippocampus and cortex. It is reported 
that the NPY release is closely related to glutamatergic 
stimulation. Similar with SST, NPY is believed to 
be another neuropeptide which plays a prominent 
role in epileptogenesis, and acts as an endogenous 
anticonvulsant by virtue of regulating glutamate-
-mediated transmission, calcium ion influx or K+ currents 
(Meurs et al. 2012, Wang 2005, Nadler et al. 2007). In a 
recent study, the involvement of NPY in modulating 
endogenous neurogenesis within subgranular zone 
(SGZ) could contribute to the newly-generated neurons 
integrating into the local circuit (Corvino et al. 2014), 
being essential for alleviating seizure-like symptoms. 
rAAV-mediated overexpression of NPY combined with 
its special receptors is also recognized as promising 
approach for therapy of epilepsy (Noé et al. 2009, Noé 
et al. 2007). Moreover, this peptide displays enhanced 
expression in different brain areas from varied epileptic 
animal models (Goto et al. 2010, Kokaia 2011), which are 
coincide with our results in this study, suggesting that 
the TRM epileptiform activity might not only make 
an effect upon SST system, but also influence NPY’s 
expression or secretion. Due to the diminished GABA 
and elevated glutamine reported in our previous study 
(Mao et al. 2011b), the increased amount of SST or NPY 
could be recognized as a self-neuroprotection against 
the aberrant neurotransmission circuitry in TRM brains. 
Although these neuropeptides are likely to take part in 
TRM self-defense process, the epileptogenesis in current 
epileptic animals do not dampened totally. A feasible 
explanation might be that the amount of these peptides 
is not sufficient to be completely effective during 
this process. It is noteworthy that compared with our 
previous research (Xu et al. 2014), different product of 
NPY primary antibody and new experimental animals 
were employed for histological analysis in current study 
for the purpose of reconfirming former results. Similar 
conclusions we got here also illustrate that our data 
could be repeatable and convincible. 
In addition, remarkable neuron loss and mossy fiber 
sprouting are not discovered in TRM brain regions reported 
by previous research (Hanaya et al. 2010), indicating that 
the increased SST expression here possibly represented 
a functionally activated population of neurons involved 
in antiepileptic action. As a regulator, SST could modulate 
Fig. 4. The representative images of TRM and control temporal lobe 
cortex and cerebellum showing DAB‑stained SST. (A) The distribution of 
SST is observed in temporal lobe cortex and cerebellar Purkinje layer. 
Two each of the representative neurons which have positive or negative 
immuno‑signals was pointed out by arrow and arrowheads respectively. 
(B)  The analysis of SST positive cells. In TRM temporal lobe cortex, the 
number of SST positive cells are more than control rats. Scale bars: 
20 μm. *p<0.05 vs. control group; **p<0.01 vs. control group. Con=control, 
TLC=temporal lobe cortex, CE=cerebellum, EC=entorhinal cortex, 
GCL=granular cell layer, PKL=Purkinje layer, ML=molecular layer.
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excitatory input from entorhinal cortex into hippocampus 
and then granule cells in the molecular layer transmit this 
information to CA3 neurons. Therefore, CA3 is considered 
to be the “pacemaker” of seizures in hippocampus 
(Tallent and Qiu 2008), suggesting that its role could 
be more crucial than CA1, which may partly explain no 
significant change of SST immunoreactions in this region. 
In TRM hippocampal CA3 and the temporal lobe cortex, 
the higher immuno-signal of SST may be due to epileptic 
activity-dependent release to exert a self-protection, 
which is elucidated in other researches as well (Schwarzer 
et al. 1996, Wanscher et al. 1990). On the other hand, there 
are studies showing reduced density of SST neurons in 
hilus from several animal models and patients of temporal 
lobe epilepsy (de Lanerolle et al. 1989, Choi et al. 2007), 
which is contrary to what we discovered in current study. 
Samples from different epileptic models might partly lead 
to this discrepancy, further demonstrating the molecular 
Fig. 5. The representative images of TRM and control rat hippocampus showing DAB‑stained NPY. (A) The distribution of NPY is observed in hippocampal 
CA1, CA3 and the hilus. Two each of the representative neurons which have positive or negative immuno‑signals was pointed out by arrow and arrowheads 
respectively. (B) The analysis of NPY positive cells. In all the areas mentioned above of TRM, the number of SST positive cells are increased compared with 
control rats. Scale bars: 20 μm. *p<0.05 vs. control group; **p<0.01 vs. control group. Con=control, SR=stratum radiatum, SP=pyramidal layer, SO=stratum 
oriens, OB=outer blade of the dentate gyrus, GCL=granular cell layer, IB=inner blade of the dentate gyrus, H=hilus.
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mechanism in epilepsy is complicated. However, it should 
be no doubt that the increase of SST-positive neurons 
may play a significant role in TRM epileptogenesis.
Compare with SST, the enhanced expression of NPY in 
all the subareas of TRM hippocampus and temporal lobe 
cortex may reveal its more rapid and durable reaction 
to seizures. In line with our study, it has been reported 
that an obvious increase of NPY in hippocampal CA1 
and CA3 from experimental febrile seizures (Dubé et al. 
2005). Furthermore, we particularly focused on the area 
of hilus in TRM which were not included in our previous 
DG analysis. NPY could be produced by a subpopulation 
of GABAergic interneurons located in hilus (Sperk et 
al. 2007), thus the added NPY positive cells in TRM 
hilus might be proposed a possible anticonvulsant and 
neuroprotective role of NPY here. In certain epileptic 
models, the loss of neurons containing NPY is less evident 
than those containing SST (Clynen et al. 2014), implying 
the distinct function or acting mechanism between them. 
Finally, considering the possible role of cerebellum in 
epileptiform events reported in former researches (Li et al. 
2010, Striano et al. 2013, Boop et al. 2013), we also selected 
TRM cerebellum as one of our objects to study. We noticed 
that in TRM cerebellum, neither SST nor NPY was detected 
unusual expression on mRNA level or peptide level. The 
immunoreaction of these neuropeptides in Purkinje cells 
or granular cells showed no altered change compare with 
Wistar rats, prompting that this brain region might be not 
as sensitive as hippocampus or temporal lobe cortex to 
TRM epileptogenesis. This result may also hint on that, 
besides SST and NPY, other members of neuropeptides 
could participate in TRM epileptic generation. Hence, 
further work will be essential to verify these assumptions.
In summary, the current study investigated the 
expression and distribution of two members of 
neuropeptide family: SST and NPY in TRM brains, 
including hippocampus, temporal lobe cortex and 
cerebellum. According to our data, we speculate that the 
altered expression of SST and NPY might be adaptive 
reactions to TRM epileptogenesis, suggesting that an 
endogenous neuroprotective system might be activated 
spontaneously. However, more researches are certainly 
demanded in order to explain why this protection is not 
effective enough to suppress epileptiform events in TRM. 
On the other hand, the anticonvulsive function displayed 
by SST and NPY may provide more promising approaches 
to control neuronal hyperexcitability via exogenous 
administration or gene therapy, which will be extremely 
meaningful in treatment of inherited epilepsy. 
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